Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index

Concomitant medications are known to impact on clinical outcomes of patients treated with immune checkpoint inhibitors (ICIs). We aimed weighing the role of different concomitant baseline medications  to create a drug-based prognostic score.

Source: European Journal of Cancer - November 16, 2020 Category: Cancer & Oncology Authors: Sebastiano Buti, Melissa Bersanelli, Fabiana Perrone, Marcello Tiseo, Marco Tucci, Vincenzo Adamo, Luigia S. Stucci, Alessandro Russo, Enrica T. Tanda, Francesco Spagnolo, Francesca Rastelli, Federica Pergolesi, Daniele Santini, Marco Russano, Cecilia Ane Tags: Original Research Source Type: research